Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection

Conditions

• Compensated Liver Disease (Disorder)
• Hepatitis D, Chronic

Interventions

• OTHER: Stop Treatment with Bulevertide in patients with compensated liver disease and chronic HDV infection

Sponsor

Hannover Medical School

Collaborators

• [object Object]
• [object Object]